Zydus 400 mg (Tablet)
Unit Price: ৳ 40.00 (2 x 7: ৳ 560.00)
Strip Price: ৳ 280.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Moxifloxacin hydrochloride tablet |
| Company | Healthcare pharmaceuticals ltd |
Indications
- Treatment of acute bacterial sinusitis
- Treatment of acute exacerbation of chronic bronchitis
- Treatment of community acquired pneumonia
- Treatment of uncomplicated skin and skin structure infections
- Treatment of complicated skin and skin structure infections
- Treatment of complicated intra-abdominal infections
- Treatment of pelvic inflammatory disease
Pharmacology
- 4th generation synthetic broad spectrum antibacterial
- Fluoroquinolone class of antibacterial drug
- Activity against gram-positive, gram-negative, anaerobic and atypical bacteria
- Inhibition of topoisomerase II and IV
Dosage & Administration
- 400 mg once daily for acute bacterial sinusitis
- 400 mg once daily for bacterial exacerbation of chronic bronchitis
- 400 mg once daily for community-acquired pneumonia
- 400 mg once daily for uncomplicated skin and skin structure infections
- 400 mg once daily for complicated skin and skin structure infections
- 400 mg once daily for complicated intra-abdominal infections
- 400 mg once daily for pelvic inflammatory disease
Interaction
- Decreased absorption with antacids, sucralfate, multivitamins, and multivalent cations
- Enhanced risk of convulsions with NSAIDs
- Enhanced risk of bleeding with warfarin
Contraindications
- History of hypersensitivity to Moxifloxacin or other quinolones
Side Effects
- Nausea
- Vomiting
- Diarrhea
- Headache
- Dizziness
Pregnancy & Lactation
- US FDA pregnancy category C
- Not recommended during pregnancy and lactation
Precautions & Warnings
- Increased risk of tendinitis and tendon rupture
- Discontinuation if pain or inflammation in a tendon occurs
- Not to be used in patients with known prolongation of the QT interval
- Not to be used in patients with uncorrected hypokalemia
- Not to be used in patients receiving Class IA or Class III antiarrhythmic agents
Use in Special Populations
- No dose adjustment necessary for renal or hepatic impaired patients
- Safety and effectiveness in pediatric patients not established
Therapeutic Class
- 4-quinolone preparations
Storage Conditions
- Keep in a dry place
- Keep away from light and heat
- Keep out of the reach of children